Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
104.94
Dollar change
+0.01
Percentage change
0.01
%
Index- P/E14.24 EPS (ttm)7.37 Insider Own0.00% Shs Outstand2.04B Perf Week0.41%
Market Cap205.31B Forward P/E13.18 EPS next Y7.96 Insider Trans- Shs Float1.96B Perf Month2.31%
Income15.24B PEG1.36 EPS next Q1.82 Inst Own7.26% Short Float0.20% Perf Quarter8.95%
Sales48.66B P/S4.22 EPS this Y12.22% Inst Trans-9.03% Short Ratio2.57 Perf Half Y7.74%
Book/sh19.44 P/B5.40 EPS next Y9.67% ROA8.86% Short Interest3.92M Perf Year8.91%
Cash/sh4.98 P/C21.06 EPS next 5Y10.51% ROE19.96% 52W Range88.86 - 108.78 Perf YTD3.93%
Dividend Est.3.73 (3.55%) P/FCF16.15 EPS past 5Y5.63% ROI26.11% 52W High-3.53% Beta0.57
Dividend TTM3.74 (3.56%) Quick Ratio0.71 Sales past 5Y0.78% Gross Margin72.13% 52W Low18.09% ATR (14)1.22
Dividend Ex-DateMar 07, 2024 Current Ratio0.90 EPS Y/Y TTM126.83% Oper. Margin27.40% RSI (14)59.88 Volatility1.06% 0.85%
Employees76057 Debt/Eq0.69 Sales Y/Y TTM-4.53% Profit Margin31.33% Recom2.46 Target Price112.10
Option/ShortYes / Yes LT Debt/Eq0.47 EPS Q/Q20.88% Payout44.73% Rel Volume0.69 Prev Close104.93
Sales Surprise3.40% EPS Surprise7.29% Sales Q/Q-8.68% EarningsApr 23 BMO Avg Volume1.53M Price104.94
SMA201.45% SMA505.02% SMA2005.98% Trades Volume1,048,675 Change0.01%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Buy $120
Feb-23-24Initiated BMO Capital Markets Market Perform $114
Jan-23-24Initiated Morgan Stanley Equal-Weight $114
Jan-16-24Resumed UBS Buy
Dec-18-23Downgrade HSBC Securities Buy → Hold
Sep-25-23Upgrade Morgan Stanley Underweight → Equal-Weight
Jul-14-23Initiated HSBC Securities Buy
Apr-26-23Upgrade Deutsche Bank Hold → Buy
Mar-27-23Upgrade Deutsche Bank Sell → Hold
Jan-26-23Downgrade Citigroup Buy → Neutral
Jun-17-24 03:27PM
Jun-16-24 08:12PM
Jun-12-24 06:00AM
Jun-11-24 12:54PM
11:04AM
08:37AM Loading…
08:37AM
Jun-06-24 09:40AM
04:00AM
Jun-04-24 02:18PM
09:50AM
May-31-24 01:02PM
12:38PM
12:18PM
08:00AM
06:55AM
04:00AM Loading…
04:00AM
May-30-24 06:01PM
May-28-24 06:50AM
04:35AM
May-27-24 12:29PM
04:25AM
04:25AM
May-25-24 11:10PM
06:15AM
06:00AM
May-23-24 05:21PM
May-22-24 05:17PM
04:56AM
May-17-24 05:51AM
May-16-24 01:00PM
07:15AM Loading…
07:15AM
06:15AM
05:27AM
May-15-24 10:00AM
08:19AM
May-14-24 06:30AM
12:20AM
May-11-24 09:46AM
May-10-24 06:30AM
May-08-24 03:15PM
May-07-24 07:00AM
May-05-24 02:25PM
May-03-24 04:06PM
01:08PM
12:36PM
08:15AM
May-02-24 03:58PM
01:59PM
11:54AM
10:30AM
08:20AM
07:36AM
07:30AM
03:01AM
May-01-24 09:09PM
01:46PM
01:46PM
11:12AM
10:00AM
Apr-30-24 11:50AM
07:00AM
04:14AM
Apr-25-24 08:30AM
Apr-24-24 11:42AM
10:54AM
10:30AM
Apr-23-24 06:25PM
05:05PM
04:01PM
03:18PM
02:38PM
01:54PM
01:42PM
12:53PM
12:34PM
12:24PM
12:16PM
12:15PM
12:07PM
11:32AM
11:15AM
10:51AM
09:30AM
09:00AM
08:59AM
08:52AM
07:45AM
07:29AM
05:15AM
05:02AM
04:58AM
04:31AM
04:08AM
03:01AM
01:18AM
01:00AM
Apr-22-24 06:08PM
Apr-19-24 10:10AM
Apr-18-24 06:33PM
09:15AM
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.